- Latest available (Revised)
- Point in Time (24/12/2020)
- Original (As made)
Point in time view as at 24/12/2020.
There are currently no known outstanding effects for the The Social Care Staff Support Fund (Coronavirus) (Scotland) Regulations 2020.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
Regulation 3(6)
Textual Amendments
F1Schs. 1, 2 inserted (24.12.2020) by The Social Care Staff Support Fund (Coronavirus) (Scotland) Amendment Regulations 2020 (S.S.I. 2020/469), regs. 1(1), 2(8)
A person who has cancer and is receiving a course of chemotherapy
A person who has lung cancer and is either receiving, or has previously received, radiotherapy intended to cure the cancer
A person who has cancer of the blood or bone marrow (including leukaemia, lymphoma or myeloma) and is at any stage of treatment
A person with a severe chest condition such as cystic fibrosis, severe asthma, severe chronic obstructive pulmonary disease, severe bronchiectasis or pulmonary hypertension
A person with a rare disease, including all forms of interstitial lung disease/sarcoidosis, and inborn errors of metabolism (such as severe combined immunodeficiency and homozygous sickle cell) that significantly increase the risk of infections
A person with an absent spleen or who has had their spleen removed
A person who is pregnant and who has significant heart disease (whether congenital or acquired)
A person aged 18 or over with Down’s syndrome
A person with stage 5 kidney disease
A person who has had solid organ transplants
A person who has had bone marrow or stem cell transplants in the last six months, or who is taking immunosuppression drugs
A person who is receiving immunotherapy or other continuing antibody treatments for cancer
A person who is receiving targeted cancer treatments which can affect the immune system, such as protein kinase inhibitors or poly (ADP-ribose) polymerase inhibitors
A person who is receiving immunosuppression therapies that significantly increase the risk of infection
A person who is receiving renal dialysis treatment
Regulation 3(7)
A person who is aged 70 or older
A person who is under 70 and instructed to get a flu jab each year on medical grounds
A person who is pregnant
A person with chronic respiratory diseases, such as asthma, chronic obstructive pulmonary disease, emphysema or bronchitis
A person with chronic heart disease
A person with chronic kidney disease
A person with chronic liver disease
A person with a chronic neurological condition, including Parkinson’s diease, motor neurone disease, multiple sclerosis, a learning disability or cerebral palsy
A person with diabetes
A person who has problems with their spleen, for example sickle cell disease
A person with a weakened immune system as the result of conditions such as human immunodeficiency virus or acquired immune deficiency syndrome, or as a result of medicines such as steroid tablets or chemotherapy
A person with a body mass index of 40 or above]
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Policy Note sets out a brief statement of the purpose of a Scottish Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Scottish Statutory Instrument accessible to readers who are not legally qualified and accompany any Scottish Statutory Instrument or Draft Scottish Statutory Instrument laid before the Scottish Parliament from July 2012 onwards. Prior to this date these type of notes existed as ‘Executive Notes’ and accompanied Scottish Statutory Instruments from July 2005 until July 2012.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: